Cargando…

Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy

BACKGROUND: Amoxicillin (AX) is nowadays the β‐lactam that more frequently induces immediate allergic reactions. Nevertheless, diagnosis of AX allergy is occasionally challenging due to risky in vivo tests and non‐optimal sensitivity of in vitro tests. AX requires protein haptenation to form multiva...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesfaye, Amene, Rodríguez‐Nogales, Alba, Benedé, Sara, Fernández, Tahía D., Paris, Juan L., Rodriguez, Maria J., Jiménez‐Sánchez, Isabel M., Bogas, Gador, Mayorga, Cristobalina, Torres, María J., Montañez, María I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518075/
https://www.ncbi.nlm.nih.gov/pubmed/33784407
http://dx.doi.org/10.1111/all.14834
_version_ 1784584145787158528
author Tesfaye, Amene
Rodríguez‐Nogales, Alba
Benedé, Sara
Fernández, Tahía D.
Paris, Juan L.
Rodriguez, Maria J.
Jiménez‐Sánchez, Isabel M.
Bogas, Gador
Mayorga, Cristobalina
Torres, María J.
Montañez, María I.
author_facet Tesfaye, Amene
Rodríguez‐Nogales, Alba
Benedé, Sara
Fernández, Tahía D.
Paris, Juan L.
Rodriguez, Maria J.
Jiménez‐Sánchez, Isabel M.
Bogas, Gador
Mayorga, Cristobalina
Torres, María J.
Montañez, María I.
author_sort Tesfaye, Amene
collection PubMed
description BACKGROUND: Amoxicillin (AX) is nowadays the β‐lactam that more frequently induces immediate allergic reactions. Nevertheless, diagnosis of AX allergy is occasionally challenging due to risky in vivo tests and non‐optimal sensitivity of in vitro tests. AX requires protein haptenation to form multivalent conjugates with increased size to be immunogenic. Knowing adduct structural features for promoting effector cell activation would help to improve in vitro tests. We aimed to identify the optimal structural requirement in specific cellular degranulation to AX using well‐precised nanoarchitectures of different lengths. METHOD: We constructed eight Bidendron Antigens (BiAns) based on polyethylene glycol (PEG) linkers of different lengths (600–12,000 Da), end‐coupled with polyamidoamine dendrons that were terminally multi‐functionalized with amoxicilloyl (AXO). In vitro IgE recognition was studied by competitive radioallergosorbent test (RAST) and antibody–nanoarchitecture complexes by transmission electron microscopy (TEM). Their allergenic activity was evaluated using bone marrow‐derived mast cells (MCs) passively sensitized with mouse monoclonal IgE against AX and humanized RBL‐2H3 cells sensitized with polyclonal antibodies from sera of AX‐allergic patients. RESULTS: All BiAns were recognized by AX‐sIgE. Dose‐dependent activation responses were observed in both cellular assays, only with longer structures, containing spacers in the range of PEG 6000–12,000 Da. Consistently, greater proportion of immunocomplexes and number of antibodies per complex for longer BiAns were visualized by TEM. CONCLUSIONS: BiAns are valuable platforms to study the mechanism of effector cell activation. These nanomolecular tools have demonstrated the importance of the adduct size to promote effector cell activation in AX allergy, which will impact for improving in vitro diagnostics.
format Online
Article
Text
id pubmed-8518075
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85180752021-10-21 Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy Tesfaye, Amene Rodríguez‐Nogales, Alba Benedé, Sara Fernández, Tahía D. Paris, Juan L. Rodriguez, Maria J. Jiménez‐Sánchez, Isabel M. Bogas, Gador Mayorga, Cristobalina Torres, María J. Montañez, María I. Allergy ORIGINAL ARTICLES BACKGROUND: Amoxicillin (AX) is nowadays the β‐lactam that more frequently induces immediate allergic reactions. Nevertheless, diagnosis of AX allergy is occasionally challenging due to risky in vivo tests and non‐optimal sensitivity of in vitro tests. AX requires protein haptenation to form multivalent conjugates with increased size to be immunogenic. Knowing adduct structural features for promoting effector cell activation would help to improve in vitro tests. We aimed to identify the optimal structural requirement in specific cellular degranulation to AX using well‐precised nanoarchitectures of different lengths. METHOD: We constructed eight Bidendron Antigens (BiAns) based on polyethylene glycol (PEG) linkers of different lengths (600–12,000 Da), end‐coupled with polyamidoamine dendrons that were terminally multi‐functionalized with amoxicilloyl (AXO). In vitro IgE recognition was studied by competitive radioallergosorbent test (RAST) and antibody–nanoarchitecture complexes by transmission electron microscopy (TEM). Their allergenic activity was evaluated using bone marrow‐derived mast cells (MCs) passively sensitized with mouse monoclonal IgE against AX and humanized RBL‐2H3 cells sensitized with polyclonal antibodies from sera of AX‐allergic patients. RESULTS: All BiAns were recognized by AX‐sIgE. Dose‐dependent activation responses were observed in both cellular assays, only with longer structures, containing spacers in the range of PEG 6000–12,000 Da. Consistently, greater proportion of immunocomplexes and number of antibodies per complex for longer BiAns were visualized by TEM. CONCLUSIONS: BiAns are valuable platforms to study the mechanism of effector cell activation. These nanomolecular tools have demonstrated the importance of the adduct size to promote effector cell activation in AX allergy, which will impact for improving in vitro diagnostics. John Wiley and Sons Inc. 2021-05-05 2021-10 /pmc/articles/PMC8518075/ /pubmed/33784407 http://dx.doi.org/10.1111/all.14834 Text en © 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle ORIGINAL ARTICLES
Tesfaye, Amene
Rodríguez‐Nogales, Alba
Benedé, Sara
Fernández, Tahía D.
Paris, Juan L.
Rodriguez, Maria J.
Jiménez‐Sánchez, Isabel M.
Bogas, Gador
Mayorga, Cristobalina
Torres, María J.
Montañez, María I.
Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title_full Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title_fullStr Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title_full_unstemmed Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title_short Nanoarchitectures for efficient IgE cross‐linking on effector cells to study amoxicillin allergy
title_sort nanoarchitectures for efficient ige cross‐linking on effector cells to study amoxicillin allergy
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518075/
https://www.ncbi.nlm.nih.gov/pubmed/33784407
http://dx.doi.org/10.1111/all.14834
work_keys_str_mv AT tesfayeamene nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT rodrigueznogalesalba nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT benedesara nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT fernandeztahiad nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT parisjuanl nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT rodriguezmariaj nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT jimenezsanchezisabelm nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT bogasgador nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT mayorgacristobalina nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT torresmariaj nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy
AT montanezmariai nanoarchitecturesforefficientigecrosslinkingoneffectorcellstostudyamoxicillinallergy